"Symptom Flare Up" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A transient exacerbation of symptoms of an existing disease or condition.
| Descriptor ID |
D000067251
|
| MeSH Number(s) |
C23.550.291.937.500
|
| Concept/Terms |
Symptom Flare Up- Symptom Flare Up
- Flare Up, Symptom
- Flare Ups, Symptom
- Symptom Flare Ups
- Symptom Flaring Up
- Flaring Up, Symptom
- Flaring Ups, Symptom
- Symptom Flaring Ups
- Acute Symptom Flare
- Acute Symptom Flares
- Flare, Acute Symptom
- Flares, Acute Symptom
- Symptom Flare, Acute
- Symptom Flares, Acute
- Symptom Flareup
- Flareup, Symptom
- Flareups, Symptom
- Symptom Flareups
- Symptom Flare-up
- Flare-up, Symptom
- Flare-ups, Symptom
- Symptom Flare-ups
|
Below are MeSH descriptors whose meaning is more general than "Symptom Flare Up".
Below are MeSH descriptors whose meaning is more specific than "Symptom Flare Up".
This graph shows the total number of publications written about "Symptom Flare Up" by people in this website by year, and whether "Symptom Flare Up" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Symptom Flare Up" by people in Profiles.
-
An Insight into Patients' Perspectives of Ulcerative Colitis Flares via Analysis of Online Public Forum Posts. Inflamm Bowel Dis. 2024 Oct 03; 30(10):1748-1758.
-
Association of substance use with outcomes in mildly ill COVID-19 outpatients. Am J Emerg Med. 2023 12; 74:27-31.
-
Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE Trial. Am J Nephrol. 2021; 52(12):969-976.
-
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study. Lancet Gastroenterol Hepatol. 2022 01; 7(1):28-37.
-
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. Lancet Gastroenterol Hepatol. 2022 01; 7(1):17-27.
-
Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes. Dig Dis Sci. 2021 02; 66(2):577-586.
-
Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS Cohort. Chest. 2020 04; 157(4):856-865.
-
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. Arthritis Rheumatol. 2019 03; 71(3):451-459.
-
Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study. Chest. 2019 03; 155(3):519-527.
-
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease. Arthritis Rheumatol. 2018 09; 70(9):1508-1518.